Bank Of America Corp Esperion Therapeutics, Inc. Transaction History

Bank Of America Corp

  • $1.43 Trillion
  • Q3 2025

A detailed history of Bank Of America Corp transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 304,572 shares of ESPR stock, worth $883,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
304,572
Previous 836,339 63.58%
Holding current value
$883,258
Previous $819,000 1.47%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.98 - $2.84 $521,131 - $1.51 Million
-531,767 Reduced 63.58%
304,572 $807,000
Q2 2025

Aug 14, 2025
SELL
$0.73 - $1.41 $504,374 - $974,202
-690,924 Reduced 45.24%
836,339 $819,000
Q1 2025

May 15, 2025
SELL
$1.44 - $2.34 $147,912 - $240,357
-102,717 Reduced 6.3%
1,527,263 $2.2 Million
Q4 2024

Feb 14, 2025
BUY
$1.61 - $3.83 $815,349 - $1.94 Million
506,428 Added 45.07%
1,629,980 $3.59 Million
Q3 2024

Nov 14, 2024
SELL
$1.61 - $2.73 $64,193 - $108,850
-39,872 Reduced 3.43%
1,123,552 $1.85 Million
Q2 2024

Aug 14, 2024
SELL
$1.84 - $3.24 $6.22 Million - $11 Million
-3,381,836 Reduced 74.4%
1,163,424 $2.58 Million
Q1 2024

May 15, 2024
BUY
$2.02 - $3.02 $8.82 Million - $13.2 Million
4,368,724 Added 2474.69%
4,545,260 $12.2 Million
Q4 2023

Feb 14, 2024
SELL
$0.73 - $3.08 $5,537 - $23,361
-7,585 Reduced 4.12%
176,536 $527,000
Q2 2023

Aug 14, 2023
SELL
$1.2 - $1.76 $394,893 - $579,177
-329,078 Reduced 64.12%
184,121 $255,000
Q1 2023

May 12, 2023
BUY
$1.46 - $7.3 $621,527 - $3.11 Million
425,704 Added 486.55%
513,199 $815,000
Q4 2022

Feb 10, 2023
BUY
$5.09 - $8.5 $110,600 - $184,696
21,729 Added 33.04%
87,495 $545,000
Q3 2022

Nov 14, 2022
SELL
$5.45 - $8.13 $48,101 - $71,755
-8,826 Reduced 11.83%
65,766 $440,000
Q2 2022

Aug 12, 2022
SELL
$4.77 - $6.67 $65,926 - $92,186
-13,821 Reduced 15.63%
74,592 $474,000
Q1 2022

May 16, 2022
SELL
$3.34 - $5.56 $168,135 - $279,890
-50,340 Reduced 36.28%
88,413 $410,000
Q4 2021

Feb 08, 2022
BUY
$4.81 - $11.92 $296,320 - $734,331
61,605 Added 79.85%
138,753 $694,000
Q3 2021

Nov 15, 2021
BUY
$11.34 - $21.37 $578,566 - $1.09 Million
51,020 Added 195.27%
77,148 $929,000
Q2 2021

Sep 13, 2021
BUY
$19.4 - $28.71 $506,883 - $750,134
26,128 New
26,128 $553,000

Others Institutions Holding ESPR

# of Institutions
215
Shares Held
114M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email